Researcher
School of Pharmacy, Ningxia Medical University, 1160 Shengli Street, 750004 Yinchuan, China.
2 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
This is a technical report describing an unrefereed model architecture with internal human evaluations but no peer-reviewed validation, external benchmarking, or comparative clinical/scientific outcome data.
JUL 2, 2026 · JOURNAL ARTICLE
International Journal of Pharmaceutics: X
Preclinical murine model study demonstrates nanoplatform remodels tumor microenvironment and enhances immune checkpoint blockade efficacy in triple-negative breast cancer.